Bosh sahifaIONS • NASDAQ
add
Ionis Pharmaceuticals Inc
Yopilish kursi
74,04 $
Kunlik diapazon
73,45 $ - 75,63 $
Yillik diapazon
23,95 $ - 86,74 $
Bozor kapitalizatsiyasi
12,40 mlrd USD
Oʻrtacha hajm
2,18 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 203,33 mln | -10,26% |
Joriy xarajat | 130,19 mln | 47,81% |
Sof foyda | -229,39 mln | -119,83% |
Sof foyda marjasi | -112,82 | -144,99% |
Har bir ulushga tushum | -1,15 | -166,75% |
EBITDA | -210,56 mln | -94,74% |
Amaldagi soliq stavkasi | -0,65% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,68 mlrd | 16,39% |
Jami aktivlari | 3,52 mlrd | 17,32% |
Jami passivlari | 3,03 mlrd | 25,65% |
Umumiy kapital | 489,09 mln | — |
Tarqatilgan aksiyalar | 165,19 mln | — |
Narxi/balansdagi bahosi | 24,76 | — |
Aktivlardan daromad | -16,35% | — |
Kapitaldan daromad | -18,58% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -229,39 mln | -119,83% |
Operatsiyalardan naqd pul | -137,71 mln | -18,57% |
Sarmoyadan naqd pul | -419,50 mln | -714,99% |
Moliyadan naqd pul | 591,18 mln | 1 440,05% |
Naqd pulning sof oʻzgarishi | 33,92 mln | 136,66% |
Boʻsh pul | -84,56 mln | 25,19% |
Haqida
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
Tashkil etilgan
1989
Sayt
Xodimlar soni
1 402
